imsidolimab
imsidolimab: developed by 2 companies · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (2)
| Company | Phase |
|---|---|
| ANAPTYSBIO, INC (ANAB) | BLA Filed |
| Vanda Pharmaceuticals Inc. (VNDA) | Phase 3 |
Clinical Trials (1)
A Phase 2, Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Subjects With Hidradenitis Suppurativa
Frequently asked questions
Who is developing imsidolimab?
imsidolimab is being developed by ANAPTYSBIO, INC, Vanda Pharmaceuticals Inc..
How many clinical trials involve imsidolimab?
BioSniper tracks 1 clinical trial involving imsidolimab.
Get deeper analysis on imsidolimab
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis